Companies / OCC

ORTHOCELL LIMITED

ASX:OCCPharmaceuticals, Biotechnology & Life Sciences
272.4M shares on issueASX (delayed) · snapshot 28 Oct 2026302.1M fully diluted+10.9% if every option and right converts$0.54price · delayed$145.7MMarket capAt the previous close. On a day the price moves, shares × today’s price will differ. Prices delayed.

Today’s holders own 90.2% of what they think they own, once every option and right converts.

Moderate
Dilution risk

Runway under 2 quarters; share count grew 29% in 24 months; 1 cash raise in 24 months

MinimalVery high
Absolute levels — not a ranking against other companies.
Cash runway0.8 quarters of funding
Share-count growth (24m)29.3%
Raise cadence (24m)1 cash raise
Options & rights overhang10.9% of shares
In-the-money supply4.9% of shares
Pending proposed issuesnone

ORTHOCELL LIMITED's ordinary share count grew 29.3% between October 2024 and September 2026, its latest share-count filing, to 272M shares. The company raised capital once in the 24-month window, an A$30.0M placement in October 2025. Options and rights on issue could convert into 30M new shares, equal to 10.9% of the current share count, of which 5% are in the money; the nearest expiry falls in April 2027. The company has under 2 quarters of funding at the recent spend rate. No proposed securities issues are currently pending.

AI-generated summary of this page's cited filings · updated 23 Oct 2026
Quick answers · 5

When did OCC last raise capital?

The last capital raise in Orthocell's filings is Placement of $30.0M announced 17 Oct 2025, one of 1 cash raises in 24 months.

How much placement capacity does OCC have left?

About 99% of the 15% placement capacity left, about 1% used in 12 months (estimate). Under ASX Listing Rule 7.1 a company may place up to 15% of its shares in 12 months without shareholder approval.

How much cash does OCC have?

In its quarterly cash report for the quarter ended 30 Sept 2026, Orthocell reported $5.2M of cash and estimated 1.2 quarters of funding available at its current rate of spending. That is the company's own estimate.

When do OCC's options expire?

Unexercised options and rights equal 10.9% of Orthocell's shares on issue; the nearest expiry is Apr 2027.

How much has OCC's share count grown?

Orthocell has 272.4M shares on issue as at 28 Oct 2026, up 29.3% over 24 months according to its Appendix 2A filings.

Get told when this changes
Get OCC alerts
Free for up to 2 companies. A daily email when OCC raises money, files a new share issue, drops below 2 quarters of cash or moves risk level.
10.9%
Options & rights overhang
4.9%
In the moneyAn option whose exercise price is below the last closing share price, so converting it pays. These are the options most likely to become new shares soon. supply
0
Raises · last 12 months
0.8 qtrs
Cash cover · under 2 quarters

Shares on issue — last 2 years

Ordinary shares on issue
Weekly counts from ASX records. Dots mark cash capital raises. Latest count 272.4M per ASX (delayed) (snapshot 28 Oct 2026).
240M250M260M270MDec 24Nov 25Oct 26Cash raise · 17 Oct 2025272.4M

Cash runway

0.8 qtrs OURS
Less than two quarters of funding at the recent spend rate — near-term funding pressure.
Funds operations to about Dec 2026 at the reported spend rate.
$3.8M cash after burn.
FILED 1.2 qtrs · $5.2M cash · quarter ended 30 Sept 2026
OURS our estimate, carried to todayOURSOur estimate for today. We take the cash in the company’s latest cash report, deduct spending since at its reported rate, and, for quarterly filers, add raises announced after it. It moves daily; announced money may not all be received yet.$5.2M cash at 30 Sep 2026 − $1.4M spent ($4.6M a quarter × 28 days) = $3.8M left → 0.8 qtrsFILED as the company reportedFILEDAs the company stated it in its latest cash report. Dated to the end of that period, it does not change until the next report.
Free account
16 cash reports on record — Cash runway history
Cash, net spend and cover trend from every Appendix 4C/5B and 4D/4E on record up to 30 Sept 2026.
Free account: 2 full company unlocks every month, no card.
Unlock OCC freeSee plans

Issuance timeline

Latest 5 filings (Appendix 2AThe form a company lodges to have new securities quoted on the ASX. It restates how many of each class are on issue. quoted issues, 3G unquoted, 3H cancellations)

DateFormSecurityOn issue, per this filingSource
11 Sept 20262A · quoted issueOCC : ORDINARY FULLY PAID272.4MAppendix 2A
20 July 20262A · quoted issueOCC : ORDINARY FULLY PAID272.3MAppendix 2A
17 July 20263G · unquotedOCC : ORDINARY FULLY PAID272.3MAppendix 3G
17 July 20263G · unquotedORDINARY FULLY PAID272.3MAppendix 3G
17 July 20262A · quoted issueOCC : ORDINARY FULLY PAID272.3MAppendix 2A
Free account
52 filings on record — Full issuance history
Every quoted and unquoted issue and cancellation on record, plus unquoted securities (Appendix 4.2).
Free account: 2 full company unlocks every month, no card.
Unlock OCC freeSee plans

Securities on issue over time

Ordinary shares and every option and rights class, month by month over two years. The top edge is the fully diluted count.

Free account
Securities on issue, by class
How the share count and each option and rights class moved, month by month, with every number in a table.
Free account: 2 full company unlocks every month, no card.
Unlock OCC freeSee plans

Capital raises

1 cash raise in the last 24 months · 0 in the last 12 months

$30.0M
Placement
At $1.30, 9.1% below the last close
17 Oct 2025 COMPLETE
Free account
12 issues (incl. 7 exercises or conversions) on record — Full raise history
Issue price, shares issued, brokers and stated purpose for every raise on record.
Free account: 2 full company unlocks every month, no card.
Unlock OCC freeSee plans

Forward supply

Every dated event on record that could add securities to the register — option expiries to their stated dates and proposed issues over the next 18 months, on one timeline.

4.0M of option supply could convert within 12 months — 1.5% of shares on issue
4.0M in the money, expiring in the window
Out-of-the-money options are excluded — at today’s price they expire rather than convert. So is condition-triggered supply, which has no expiry and no price, and convertibles that convert on their own terms rather than on a date.
Free account
16 dated events on record — Forward supply calendar
Option expiries and proposed issues on one forward timeline, with the securities each could add.
Free account: 2 full company unlocks every month, no card.
Unlock OCC freeSee plans

Placement capacity

How much stock a company can place without asking holders. Listing Rule 7.1 / 7.1ARule 7.1 lets a company issue up to 15% of its shares in 12 months without a shareholder vote. Rule 7.1A adds 10% for smaller companies whose holders approve it. allows 15% of ordinary securities in any 12 months, and every Appendix 3BNotice that a company proposes to issue new securities, such as a placement. The securities are not on issue until a later filing confirms it. states how much of it an issue uses.

About 99% of the 15% placement capacity left — about 1% used by Appendix 3B filings in the last 12 months (estimate, as at 2026-10-28). Shares issued with holder approval are not added to the base, so the true headroom can be higher.
Free account
Placement capacity — LR 7.1 / 7.1A
The filings behind the figure: every Appendix 3B in the window with what it says was issued under 7.1 and 7.1A, each row linked to its filing, and how many shares are left.
Free account: 2 full company unlocks every month, no card.
Unlock OCC freeSee plans

Pending proposed issues

No proposed issues (Appendix 3B) currently pending.

Options & convertible securities

10.9%
Options & rights overhang · of current shares
4.9%
In-the-money supply · at current price
29.7M
Potential new shares
Apr 2027
Nearest expiry
What this supply is, and what converts it
  • Price-triggered24.1M · 8.9% of shares
    Options and warrants — they convert when the share price clears their exercise price.
  • Condition-triggered5.5M · 2.0% of shares
    Performance and incentive rights — they convert when a hurdle is met, not at a price, and can lapse to nothing.

Exercise price on record: 24.1M priced (of which 13.5M in the money), 5.5M where the filing never states one. A security with no exercise price is never counted in the money — nothing is paid to convert it, so there is no price for it to be above.

Each figure is the filing’s own count of securities, not a share count — a 2A never states what one security converts into.

What a price move would switch on
14.8M29.7M$0.54 now0.25× today ($0.14) — 0 of the priced supply in the money, 0.0% of shares on issue0.5× today ($0.27) — 0 of the priced supply in the money, 0.0% of shares on issue0.75× today ($0.41) — 13.5M of the priced supply in the money, 4.9% of shares on issue1× today ($0.54) — 13.5M of the priced supply in the money, 4.9% of shares on issue1.25× today ($0.68) — 16.5M of the priced supply in the money, 6.0% of shares on issue1.5× today ($0.81) — 17.5M of the priced supply in the money, 6.4% of shares on issue2× today ($1.08) — 19.7M of the priced supply in the money, 7.2% of shares on issue3× today ($1.62) — 22.6M of the priced supply in the money, 8.3% of shares on issue5× today ($2.70) — 24.1M of the priced supply in the money, 8.9% of shares on issue10× today ($5.40) — 24.1M of the priced supply in the money, 8.9% of shares on issue0.25×0.5×0.75×now1.25×1.5×2×3×5×10×

At $0.54 today, 13.5M securities are in the money (4.9% of shares on issue). No more priced supply until 1.25× today’s price, which takes it to 16.5M (6.0% of shares).

  • Priced supply in the money at the price on the axis — the curve, and the only thing on it. Ten prices, sampled: between two of them the true figure lies between the two.
  • 5.5M (18.6% of the supply above) states no exercise price at all. It cannot be called in or out of the money at any price, which is why it is hatched rather than plotted.
CodeSecurityTypeExercise priceExpiryOn issueSource
OCCAXOptionsPrice-triggered$0.3619 Apr 20273.2MFiling
OCCAAAOptionsPrice-triggered$0.8026 May 20271.0MFiling
OCCAAFOptionsPrice-triggered$0.3711 June 2027700kFiling
OCCAAGOptionsPrice-triggered$0.3711 June 2027100kFiling
OCCAAKOptionsPrice-triggered$0.6731 Oct 20273.0MFiling
OCCAACOptionsPrice-triggered$0.367 Nov 2027500kFiling
OCCAAJOptionsPrice-triggered$0.902 Dec 20272.0MFiling
OCCAWOptionsPrice-triggered$0.408 Mar 20283.0MFiling
OCCAABOptionsPrice-triggered$0.4029 May 20284.0MFiling
OCCAALOptionsPrice-triggered$1.1728 July 2028550kFiling
OCCAANOptionsPrice-triggered$1.5331 Aug 20282.0MFiling
OCCAAOOptionsPrice-triggered$1.6324 Oct 2028500kFiling
OCCAAPOptionsPrice-triggered$1.9524 Oct 20281.0MFiling
OCCAADOptionsPrice-triggered$0.4020 Nov 20282.0MFiling
OCCAAQOptionsPrice-triggered$0.8117 July 2029200kFiling
OCCAAMOptionsPrice-triggered$1.4628 July 2029400kFiling
OCCAYPerformance rightsCondition-triggered——2.0MFiling Meeting
OCCAAHRightsCondition-triggered——3.5MFiling Meeting

“Nil” is a stated nil exercise price: nothing is paid to convert. An em dash means the filing names no exercise price at all. Security is read from the filing’s own class description; an em dash there means the description is not one this table labels. One row is one security class, at the number stated in the most recent quotation application that restated it — linked, and dated, in the last column. For what expires soon across other listed companies, see the options expiry calendar.

A condition-triggered class has no exercise price and usually no expiry: what it vests on is set by a shareholder resolution, not by the register. Where the company lodged a notice of meeting before the class first appears here, it is linked as “Meeting” — that is where terms of this kind are put to shareholders. It is not confirmation that the document sets this class’s conditions, and no link appears where there is no such filing.

Free account
18 option lines on record — In-the-money value & price ladder
What each line is worth in the money today, the price ladder to the next tranche that converts, and the filing description behind every code.
Free account: 2 full company unlocks every month, no card.
Unlock OCC freeSee plans

Director dealings

DateDirectorTypeSharesOptionsOtherValueSource
20 July 2026John Van Der WielenBuy15——$12k3Y notice
17 July 2026Dr Ravi ThadhaniBuy17k3.0M—$13k3Y notice
17 July 2026John Van Der WielenBuy23k4.0M—$18k3Y notice
17 July 2026Michael McNultyBuy12k2.0M—$9k3Y notice
Free account
13 notices on record — Full dealing history
Every change-of-director's-interest notice on record, with direction and consideration.
Free account: 2 full company unlocks every month, no card.
Unlock OCC freeSee plans

Ownership

Free account
Top-20 holders & substantial holder notices
Top-20 register snapshot and substantial-holder movements, each linked to its source notice.
Free account: 2 full company unlocks every month, no card.
Create free account

Latest announcements

22 Oct 2026$PQ1 FY27 OCC Investor Presentation
22 Oct 2026$PQuarterly Activity Report & Appendix 4C
20 Oct 2026Orthocell Investor Webinar Details
13 Oct 2026$PRemplir Shows Excellent Early Prostatectomy Results
2 Oct 2026Letter to Shareholders, Notice of AGM & Proxy Form
2 Oct 2026Change of Auditor
21 Sept 2026$POrthocell Achieves First Remplir Sales in Thailand
11 Sept 2026Cleansing Notice
11 Sept 2026Application for quotation of securities - OCC
10 Sept 2026Date of AGM & Closing Date for Director Nominations
31 Aug 2026Appendix 4G
31 Aug 2026Corporate Governance Statement
31 Aug 2026$PAppendix 4E & Annual Report
12 Aug 2026Orthocell Canaccord Genuity Conference Live Webcast
11 Aug 2026Orthocell to Present at Canaccord Growth Conference
3 Aug 2026Change of Registered Office & Principal Place of Business
20 July 2026Appendix 3Y - John Van Der Wielen
20 July 2026Application for quotation of securities - OCC
17 July 2026Appendix 3Y x 4
17 July 2026Application for quotation of securities - OCC

Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 Oct 2026.